199 related articles for article (PubMed ID: 21347643)
1. Guest editorial: Cancer immunology.
Yasukawa M
Int J Hematol; 2011 Mar; 93(3):261-262. PubMed ID: 21347643
[No Abstract] [Full Text] [Related]
2. [Update on tumor immunology].
Fridman WH; Berger A; Lee RS; Tartour E
Bull Cancer; 1998 Jan; 85(1):29-30. PubMed ID: 9752341
[No Abstract] [Full Text] [Related]
3. Editorial: Approaches to Advance Cancer Vaccines to Clinical Utility.
Van Nuffel AMT; Boudousquié C; Tuyaerts S
Front Immunol; 2019; 10():2032. PubMed ID: 31507617
[No Abstract] [Full Text] [Related]
4. Cellular immunotherapy for cancer: current concepts and clinical perspectives scientific basis and approaches for therapeutic cancer vaccines. Part I.
Quatan N; Spicer J; Plunkett T; Pandha H
Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):356-65. PubMed ID: 15341440
[No Abstract] [Full Text] [Related]
5. Promises and limitations of murine models in the development of anticancer T-cell vaccines.
Lévy F; Colombetti S
Int Rev Immunol; 2006; 25(5-6):269-95. PubMed ID: 17169777
[TBL] [Abstract][Full Text] [Related]
6. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
Jäger E; Jäger D; Knuth A
Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
[No Abstract] [Full Text] [Related]
7. Cancer vaccination progress.
Pawelec G; Rees RC
Trends Mol Med; 2002 Dec; 8(12):545-6. PubMed ID: 12470983
[TBL] [Abstract][Full Text] [Related]
8. Rekindling cancer vaccines.
Branca MA
Nat Biotechnol; 2016 Oct; 34(10):1019-1024. PubMed ID: 27727216
[No Abstract] [Full Text] [Related]
9. Cancer vaccines.
Dalgleish AG
Br J Cancer; 2000 May; 82(10):1619-24. PubMed ID: 10817493
[No Abstract] [Full Text] [Related]
10. Cancer-testis antigens: targets for cancer immunotherapy.
Chen YT; Old LJ
Cancer J Sci Am; 1999; 5(1):16-7. PubMed ID: 10188055
[No Abstract] [Full Text] [Related]
11. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
Seremet T; Brasseur F; Coulie PG
Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
[TBL] [Abstract][Full Text] [Related]
12. [Tumor vaccination using monoclonal antibodies].
Veelken H
Internist (Berl); 2001 Jun; 42(6):874-83. PubMed ID: 11449634
[No Abstract] [Full Text] [Related]
13. Personalized Cancer Vaccines Advance in the Clinic.
Schmidt C
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29095978
[No Abstract] [Full Text] [Related]
14. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
Jäger D; Jäger E; Bert F; Knuth A
Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
[No Abstract] [Full Text] [Related]
15. Can we predict mutant neoepitopes in human cancers for patient-specific vaccine therapy?
Lutz ER; Jaffee EM
Cancer Immunol Res; 2014 Jun; 2(6):518-21. PubMed ID: 24795140
[No Abstract] [Full Text] [Related]
16. Conference on cancer vaccines.
Schadendorf D; Belardelli F; Ferrantini M; Parmiani G; Colombo MP
Cancer Immunol Immunother; 2000 Jul; 49(4-5):281-4. PubMed ID: 10941912
[No Abstract] [Full Text] [Related]
17. Cancer Vaccine Week, an international symposium 5-9 October 1998, New York, NY.
Pawelec G
Cancer Immunol Immunother; 1999 Feb; 47(6):352-6. PubMed ID: 10203066
[No Abstract] [Full Text] [Related]
18. Cancer vaccines in phase II/III clinical trials: state of the art and future perspectives.
Cecco S; Muraro E; Giacomin E; Martorelli D; Lazzarini R; Baldo P; Dolcetti R
Curr Cancer Drug Targets; 2011 Jan; 11(1):85-102. PubMed ID: 21062241
[TBL] [Abstract][Full Text] [Related]
19. New cancer vaccine approaches.
Kaplan JM
Drugs Today (Barc); 2004 Nov; 40(11):913-29. PubMed ID: 15645004
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of surgical malignancies.
Morse MA; Lyerly HK; Clay TM; Abdel-Wahab O; Chui SY; Garst J; Gollob J; Grossi PM; Kalady M; Mosca PJ; Onaitis M; Sampson JH; Seigler HF; Toloza EM; Tyler D; Vieweg J; Yang Y
Curr Probl Surg; 2004 Jan; 41(1):15-132. PubMed ID: 14749625
[No Abstract] [Full Text] [Related]
[Next] [New Search]
